Skip to content
healthcare.dev

Carbinoxamine Maleate

NDC 80705-120, Carbinoxamine Maleate, tablet, from TRIPOINT THERAPEUTICS, LLC.

Product NDC
80705-120
Status
Listed
Labeler
TRIPOINT THERAPEUTICS, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215476
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/80705-120 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBINOXAMINE MALEATE6 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
80705-120-308070501203030 TABLET in 1 BOTTLE (80705-120-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/91ee2e99-082a-4157-b71b-1a7c0e5464fa

Use it

Look up 80705-120 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/80705-120 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 80705-120. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.